Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms

Some drug classes showed a protective effect that was however not confirmed in multivariable analyses, underlining the importance of adjusting for a comprehensive number of covariates. Clinicians should consider the possibility that systemic corticosteroids and IL-6 inhibitors administered during acute COVID-19 may prolong the persistence of particular symptoms.

Authors

Institutions

Publication Details

Journal
Infezioni in Medicina
Published
2025-12-01
DOI
https://doi.org/10.53854/liim-3304-4
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms

Emanuela Barisione, K Loso, Gianfranco Parati, Donato Lacedonia et al.
Infezioni in Medicina
Long-Term Effects of COVID-19
article

Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms

Emanuela Barisione, K Loso, Gianfranco Parati, Donato Lacedonia, Marco Floridia, Guido Vagheggini, Stefano Figliozzi, Matteo Tosato, Maria Rosa Ciardi, Domenico Maurizio Toraldo, Piergiuseppe Agostoni, Paola Gnerre, Maria Antonietta Di Rosolini, P. Andreozzi, Paolo Bonfanti, Giuseppe Pio Martino, Silvia Zucco, Patrizia Rovere-Querini, Aldo Lo Forte, Paolo Palange, Liliana Elena Weimer, Graziano Onder
article en

Abstract

Some drug classes showed a protective effect that was however not confirmed in multivariable analyses, underlining the importance of adjusting for a comprehensive number of covariates. Clinicians should consider the possibility that systemic corticosteroids and IL-6 inhibitors administered during acute COVID-19 may prolong the persistence of particular symptoms.

Infezioni in MedicinaVol. 33(4)
Università Cattolica del Sacro Cuore (IT), University of Foggia (IT), Humanitas University (IT), Vita-Salute San Raffaele University (IT), University of Milan (IT), Istituto Superiore di Sanità (IT), Policlinico Umberto I (IT), Trinity Hospital of Augusta (US), Centro Cardiologico Monzino (IT), ASL Roma (IT), University of Ragusa (IT), Nuovo Ospedale San Giovanni di Dio (IT), Azienda Ospedaliera San Gerardo (IT), Ospedale Amedeo di Savoia (IT), Alessandro Manzoni Hospital (IT), IRCCS Ospedale San Raffaele (IT), IRCCS Istituto Auxologico Italiano (IT), Ospedale Policlinico San Martino (IT), Azienda Sanitaria Locale N. 2 Savonese (IT), Ospedale Vito Fazzi (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Usl Toscana Centro (IT), IRCCS Humanitas Research Hospital (IT), University of Milano-Bicocca (IT), International Flame Research Foundation (IT), Sapienza University of Rome (IT)
Ministero della Salute, Istituto Superiore di Sanità
Openalex Percentile: Top 45%
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.